Trial Profile
Phase 2a Safety Study of a Vaginal Matrix Ring Containing Dapivirine in a Postmenopausal Female Population
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Oct 2022
Price :
$35
*
At a glance
- Drugs Dapivirine (Primary)
- Indications HIV infections
- Focus Adverse reactions
- 04 Dec 2021 Results (n=208) of exploratory analysis comparing the prevalence and concentration of specific microbiota before and after DPV ring use in three trials (NCT02028338, NCT02010593 and NCT02808949) conducted in adolescent, lactating, and postmenopausal women, published in the Journal of Infectious Diseases.
- 04 Oct 2018 Results published in the Clinical Infectious Diseases
- 25 Feb 2016 Results assessing adherence and acceptability across study group and in random subset of 24 subjects presented at the 23rd Conference on Retroviruses and Opportunistic Infections.